Transcriptomic silencing as a potential mechanism of treatment resistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transcriptomic silencing as a potential mechanism of treatment resistance
Authors
Keywords
-
Journal
JCI Insight
Volume 5, Issue 11, Pages -
Publisher
American Society for Clinical Investigation
Online
2020-06-08
DOI
10.1172/jci.insight.134824
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma
- (2018) Jeffrey P. North et al. Nature Communications
- Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data
- (2018) Alexandre Coudray et al. PeerJ
- “Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors
- (2016) Lorena Incorvaia et al. Oncotarget
- Universal Genomic Testing Needed to Win the War Against Cancer
- (2016) Vivek Subbiah et al. JAMA Oncology
- Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms
- (2016) Maria Schwaederle et al. JAMA Oncology
- miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1
- (2015) Huanxin Liu et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
- (2015) Maria Schwaederle et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval
- (2015) Denis L. Fontes Jardim et al. JNCI-Journal of the National Cancer Institute
- Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval
- (2015) Denis L. Fontes Jardim et al. JNCI-Journal of the National Cancer Institute
- Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters
- (2015) Qiong Wu et al. Oncotarget
- Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
- (2014) Matthew D. Wilkerson et al. NUCLEIC ACIDS RESEARCH
- RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection
- (2014) Amie J. Radenbaugh et al. PLoS One
- The Neuroblastoma ALK(I1250T) Mutation Is a Kinase-Dead RTK In Vitro and In Vivo
- (2014) Christina Schönherr et al. Translational Oncology
- Dissecting the expression landscape of RNA-binding proteins in human cancers
- (2014) Bobak Kechavarzi et al. GENOME BIOLOGY
- Post-transcriptional regulation in cancer progression
- (2012) Michael Jewer et al. Journal of Cell Communication and Signaling
- Mechanisms of drug resistance in kinases
- (2011) Rina Barouch-Bentov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants
- (2011) Fiona K.E McDuff et al. MOLECULAR CARCINOGENESIS
- Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells
- (2008) M. Sun et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search